2012 Annual Meeting | Diagnostic Testing in Neuromuscular Disease

Date Saturday 03/16/13

Time 04:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Kick-Off Program

Director(s) Eduardo Nobile-Orazio, MD, PhD, FAAN

Topic(s)

Learning Objectives Participants should have a greater understanding of the appropriate indications for ordering autoantibodies in the evaluation of patients with peripheral neuropathy.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Professionalism, Medical Knowledge

Recommended Audience Trainee, General Neurologist

Teaching Styles Case-based, Didactic, Interactive

Program Evaluations

Event Timeline
04:00 PM - 04:50 PM		Autoantibodies in the Diagnosis of Treatable Motor Neuropathies Eduardo Nobile-Orazio, MD, PhD, FAAN
04:00 PM - 06:00 PM
04:50 PM - 05:00 PM		Questions and Answers
05:00 PM - 05:50 PM		Autoantibodies in the Diagnosis of Selected Demyelinating, Paraneoplastic and Autonomic Neuropathies Kenneth C. Gorson, MD
05:50 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
Eduardo Nobile-Orazio, MD, PhD, FAAN	Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Kenneth C. Gorson, MD	Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Gorson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Gorson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.

��ɫ��

��ɫ��